- Report
- December 2020
- 120 Pages
Global
From €1987EUR$2,000USD£1,652GBP
- Clinical Trials
- August 2020
- 300 Pages
Global
From €2980EUR$3,000USD£2,478GBP
- Report
- October 2019
- 170 Pages
Global
From €2583EUR$2,600USD£2,148GBP
- Report
- September 2019
- 75 Pages
United States
From €1987EUR$2,000USD£1,652GBP
- Report
- March 2018
- 255 Pages
Global
From €2583EUR$2,600USD£2,148GBP
- Report
- December 2022
- 78 Pages
Global
From €5464EUR$5,500USD£4,543GBP
- Report
- June 2022
- 124 Pages
Global
From €5464EUR$5,500USD£4,543GBP
- Report
- October 2023
- 131 Pages
Global
From €4620EUR$4,650USD£3,841GBP
- Report
- May 2023
- 147 Pages
Global
From €4620EUR$4,650USD£3,841GBP
- Report
- March 2023
- 185 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- February 2023
- 123 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- January 2023
- 175 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- September 2022
- 110 Pages
Global
From €5464EUR$5,500USD£4,543GBP
- Report
- May 2022
- 109 Pages
Global
From €5464EUR$5,500USD£4,543GBP
- Report
- May 2022
- 335 Pages
Global
From €5464EUR$5,500USD£4,543GBP
- Report
- August 2021
- 159 Pages
Global
From €2732EUR$2,750USD£2,272GBP
€5464EUR$5,500USD£4,543GBP
- Report
- July 2021
- 155 Pages
Global
From €2732EUR$2,750USD£2,272GBP
€5464EUR$5,500USD£4,543GBP
- Report
- May 2021
- 358 Pages
Global
From €1366EUR$1,375USD£1,136GBP
€2732EUR$2,750USD£2,272GBP
- Report
- March 2023
- 396 Pages
Global
From €4917EUR$5,123USD£3,950GBP
- Report
- April 2023
- 358 Pages
Global
From €4917EUR$5,123USD£3,950GBP
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more